StockData
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) stock

NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)

Close on Nov 18, 2026Market cap $6.05MP/E –Yield –

ENDRA Life Sciences gross margin

Gross margin is gross profit as a percentage of revenue.

ENDRA Life Sciences's gross margin for the twelve months ending Dec 31, 2018 was 100.0%. For fiscal 2018 it was 100.0%, against 50.9% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2018Dec 31, 2018100.0%+49.1
FY2017Dec 31, 201750.9%−3.4
FY2016Dec 31, 201654.3%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2018Mar 31, 2018100.0%+45.7
Q4 FY2017Dec 31, 201755.0%–
Q3 FY2017Sep 30, 201758.8%–
Q2 FY2017Jun 30, 201711.0%–
Q4 FY2016Dec 31, 201654.3%–

More ENDRA Life Sciences figures

See a number that looks wrong?